Erasca Competitors and Similar CompaniesClear all
Erasca's competitors and similar companies include MiNK Therapeutics and Simcha Therapeutics.
 Erasca Erasca is a clinical-stage precision oncology company that discovers, develops, and commercializes therapies for cancer patients. |  MiNK Therapeutics MiNK Therapeutics (formerly AgenTus Biosciences, AgenTus Therapeutics) is a biopharmaceutical company that develops allogeneic iNKT cell therapies to treat cancer and immune-mediated diseases. |  Simcha Therapeutics Simcha Therapeutics is a biopharmaceutical company developing engineered cytokine immunotherapy for cancer. | |
Founding Date | Founding Date 2018 | Founding Date 2017 | Founding Date 2018 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations San Diego, US HQ | Locations New York, US HQ Cambridge, GB | Locations HQ |
Employees | Employees 103 | Employees 34 | Employees 167% increase |
Valuation ($) | Valuation ($) 791 m | Valuation ($) 28.9 m | Valuation ($) N/A |
Financial | |||
Net income | Net income ($124.5m) (FY, 2025) | Net income ($12.5m) (FY, 2025) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 300m | Total funding raised N/A | Total funding raised $ 25m |
For sources of this data, please see the company profile
View Company Profiles
MiNK Therapeutics
HQ
New York, US
Employees
34
MiNK Therapeutics (formerly AgenTus Biosciences, AgenTus Therapeutics) is a biopharmaceutical company that develops allogeneic iNKT cell therapies to treat cancer and immune-mediated diseases.
View companySimcha Therapeutics
HQ
Employees
16↑ 7% increase
Simcha Therapeutics is a biopharmaceutical company developing engineered cytokine immunotherapy for cancer.
View company